- Price
- $5.94
- Day
- +6.45%
- Mkt Cap
- $213.94M
- 52W Range
- $1.00 – $6.91
- Volume
- 368.4K
- Beta
- -0.99
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
NEW YORK, July 20, 2026 /PRNewswire/ -- Purcell & Lefkowitz LLP announces that it is investigating AN2 Therapeutics, Inc. (NASDAQ: ANTX) on behalf of the company's shareholders. The investigation seeks to determine whether AN2 Therapeutics's directors breached their fiduciary duties in connection with recent corporate actions.
Read full article